ALBI Score Calculator

Understanding the ALBI Score: A Modern Liver Function Assessment

Assessing liver function accurately is crucial for diagnosing, staging, and managing various liver diseases. Traditionally, tools like the Child-Pugh score have been widely used. However, the Child-Pugh score includes subjective parameters like ascites and encephalopathy, which can lead to variability. The Albumin-Bilirubin (ALBI) score emerges as a more objective and simpler alternative, relying solely on two readily available laboratory parameters.

What is the ALBI Score?

The ALBI score is a purely biochemical index designed to assess the severity of liver dysfunction. It uses only serum albumin and total bilirubin levels, making it highly objective and less prone to inter-observer variability compared to scores that include clinical observations. Developed primarily as a prognostic indicator in patients with hepatocellular carcinoma (HCC), it has also shown utility in other chronic liver diseases, offering a more nuanced stratification of liver function.

Its strength lies in its simplicity and the fact that albumin and bilirubin are routine blood tests, making it easily applicable in diverse clinical settings globally.

How is the ALBI Score Calculated?

The ALBI score is derived from a mathematical formula incorporating the patient's total bilirubin and serum albumin levels. For accurate calculation, bilirubin is typically measured in µmol/L and albumin in g/L. Our calculator above handles unit conversions automatically to ensure the correct formula is applied, allowing you to input values in common units like mg/dL for bilirubin and g/dL for albumin.

The formula is: (0.66 × log10 Bilirubin [µmol/L]) + (-0.085 × Albumin [g/L])

This logarithmic transformation of bilirubin helps to capture the non-linear relationship between bilirubin levels and liver dysfunction more effectively.

Interpreting Your ALBI Score

The calculated ALBI score falls into one of three grades, each indicating a different level of liver function and associated prognosis:

• ALBI Grade 1: Score ≤ -2.60
  Indicates excellent liver function. Patients in this grade generally have the best prognosis among those with liver disease, suggesting robust hepatic reserve.
• ALBI Grade 2: Score > -2.60 to ≤ -1.39
  Represents moderately impaired liver function. This is the most common grade for many patients with chronic liver disease and indicates an intermediate prognosis. Treatment strategies are often tailored based on this grade.
• ALBI Grade 3: Score > -1.39
  Signifies severely impaired liver function. Patients in this category have a poorer prognosis, reflecting significant hepatic decompensation. This grade often guides decisions towards more palliative care or eligibility for advanced therapies.

It's important to remember that the ALBI score is a continuous measure, and these grades serve as useful clinical benchmarks for stratification.

Advantages of the ALBI Score

The ALBI score offers several significant advantages:

• Objectivity: It eliminates subjective assessments (like ascites or encephalopathy) found in other scores, reducing variability.
• Simplicity: Requires only two routine laboratory tests, making it easy to calculate and widely applicable.
• Prognostic Accuracy: Studies have shown it to be a powerful and reliable predictor of prognosis, particularly in patients with HCC.
• Better Stratification: It can often provide better stratification of patients with early-stage liver disease than the Child-Pugh score, revealing subtle differences in liver function.
• Reproducibility: Its reliance on objective data ensures consistent results across different clinicians and institutions.

Limitations and Considerations

While highly valuable, the ALBI score is not without limitations:

• Not a Diagnostic Tool: It assesses liver function severity but does not diagnose the underlying cause of liver disease.
• Context is Key: Should always be interpreted in the context of the patient's overall clinical picture, including etiology of liver disease, comorbidities, and treatment history.
• Specific Populations: While broadly applicable, its initial validation was strong in HCC. Its utility in other specific liver diseases is still under active research.
• Dynamic Nature: Liver function can change over time; therefore, the ALBI score should be re-evaluated periodically.

Conclusion

The ALBI score represents a significant advancement in the objective assessment of liver function. Its simplicity, objectivity, and proven prognostic capability make it an invaluable tool for clinicians, especially in the management of chronic liver diseases and hepatocellular carcinoma. By providing a clear, evidence-based measure of liver health, it aids in risk stratification, treatment planning, and patient counseling. Always consult with a healthcare professional for interpretation of your specific medical results.